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Veterinary pharmaceuticals in the environment: an introduction
Abstract
The production of swine, cattle, and poultry raised for human consumption represents a significant portion of
the U.S. agricultural economy. To maximize production, livestock producers regularly use pharmaceuticals
and hormones as supplements in animal feed and water to increase rates of weight gain, and prevent or treat
diseases among their livestock. For example, in swine it is estimated that antibiotics are used for disease
prevention and growth promotion in more than 90% of starter feeds, 75% of grower feeds, 50% of finishing
feeds, and 20% of sow feeds. Equally relevant numbers are seen in beef cattle production (1-4). It has been
well documented that measurable quantities of pharmaceuticals are excreted, often in original form, in feces
and urine of livestock. Livestock waste, containing pharmaceuticals and hormones, is often used as fertilizer
for farm fields or pastures and may result in nonpoint source pollution of ground or surface waters (5). Field
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Veterinary pharmaceuticals in the 
environment: an introduction 
Keri L.D. Henderson1 and Joel R. Coats1 
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The production of swine, cattle, and poultry raised for human consumption 
represents a significant portion of the U.S. agricultural economy.  To maximize 
production, livestock producers regularly use pharmaceuticals and hormones as 
supplements in animal feed and water to increase rates of weight gain, and 
prevent or treat diseases among their livestock.  For example, in swine it is 
estimated that antibiotics are used for disease prevention and growth promotion 
in more than 90% of starter feeds, 75% of grower feeds, 50% of finishing feeds, 
and 20% of sow feeds.  Equally relevant numbers are seen in beef cattle 
production (1-4).  It has been well documented that measurable quantities of 
pharmaceuticals are excreted, often in original form, in feces and urine of 
livestock.  Livestock waste, containing pharmaceuticals and hormones, is often 
used as fertilizer for farm fields or pastures and may result in nonpoint source 
pollution of ground or surface waters (5).  Field application of manure often 
involves injection or incorporation of the waste, which may bring nutrients, 
hormones, and pharmaceutical residues spatially closer to tile drainage systems.  
These drainage systems often flow directly into nearby streams, rivers, or other 
waterways, and may therefore act as a source of waterway contamination.  A 
national reconnaissance study performed by Kolpin and colleagues (6) was 
among the first to bring widespread attention to the issue of pharmaceuticals in 
the environment.  Many studies have examined environmental chemistry and 
ecotoxicology of human drugs, however fewer have examined veterinary 
pharmaceuticals. 
Although pharmaceutical residues have been studied extensively in tissues 
and excrement, relatively little is known about the environmental fate of 
pharmaceuticals, hormones, and their metabolites once the excreta reaches soil 
and water environments (7,8).  Sorption of chemicals onto solid phases, such as 
soil or sediment, or degradation is extremely important because it could affect 
the fate and impact of these substances in that environment. 
Recently, veterinary pharmaceuticals were found in 48% of 139 stream 
waters tested in 30 states, according to the United States Geological Survey (6).  
Recent sediment monitoring studies by Kim and Carlson (9,10) detected 
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extractable antibiotic residues up to 0.1 mg/kg in sediment from an impacted 
river; typical concentrations were 0.001 to 0.03 mg/kg.  The significance of low 
concentrations of veterinary pharmaceuticals in lagoon water, soil, and surface 
water ecosystems is not well understood, particularly when so few data are 
available regarding sorption and bioavailability of hormones and 
pharmaceuticals in environmental matrices.  Simply detecting the compounds 
does not provide adequate information on the ecological significance.  These 
concentrations appear to be too low for significant activity; however ecotoxicity 
data exist for only a small number of compounds.  Low or transient 
concentrations of pharmaceuticals could have several effects; in addition to the 
obvious potential effects based on mode of action, they may have secondary 
modes of action causing harm to non-target populations in aquatic and terrestrial 
habitats. 
Even at low environmental concentrations, hormones and pharmaceuticals 
and their metabolites may be biologically active in environmental matrices; 
these compounds are designed to elicit specific effects, and while those effects 
may not lead to mortality, the may significantly alter physiology or behavior, 
thus impacting organismal fitness.  For example, antibiotics entering the 
environment could potentially alter bacterial populations and their activity in 
soil, sediment, and water, thus affecting biodegradation, nutrient cycling, and 
water quality.  In addition, there is concern that antibiotics in the environment 
may induce antibiotic resistance, resulting in adverse human health effects.  
Certainly, there is significant evidence for development of antibiotic resistance 
within animals and in the excretion of antibiotic-resistant bacteria in manure 
(11-13).  Much less is known about the ability of low concentrations of 
antibiotics to induce resistance in the environmental microbial population or to 
provide selective pressure for maintenance of antibiotic resistance genes among 
microorganisms, although the transfer of antibiotic-resistance from agricultural 
settings to humans has been reported (14).  Similarly, low concentrations of 
hormones have also demonstrated potential biological activity (15-20). 
There are concerns over potential direct and indirect effects of 
pharmaceuticals on non-target eukaryotic organisms in important habitats found 
across agricultural landscapes.  In particular, small ponds and wetlands that 
serve as key breeding sites for amphibians and support invertebrate communities 
that provide food for migrating birds (21) can receive significant amounts of 
contaminated agricultural runoff, which could contain pharmaceutical residues 
(22,23).  The aquatic risk of these chemicals has not been extensively 
characterized (24,25); even less is known about potential implications for 
terrestrial habitats.   
Studies on the fate, bioavailability, and effects of veterinary 
pharmaceuticals in terrestrial and aquatic systems will lead to improved 
management practices through the understanding of the potential for risk to the 
environment.  Studies presented in this book provide information that is 
essential to understanding the environmental mobility and degradation of 
veterinary pharmaceuticals and hormones.  Bioavailability studies serve as a 
crucial link to understanding the likelihood of environmental residues impacting 
species or microbial communities in a negative way.  Published reports have 
confirmed that very low levels of residues are detected in water and sediment 
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monitoring studies (6,9,10,26,27), but the significance of those residues will 
depend, to a great extent, on their biological availability.  Ecotoxicological 
studies herein point to possible impacts of pharmaceutical and hormone residues 
on wildlife and plants; these studies are put in a risk assessment context, and 
importantly suggest unique considerations for ecological risk assessments of 
pharmaceuticals.  The synthesis of these data into this book will provide a more 
comprehensive evaluation of the fate and potential effects of these contaminants 
in the environment, leading to more informed management decisions. 
The purpose of this symposium was to bring together scientists from 
academia, government, and industry to discuss and present data relevant to the 
potential significance of veterinary pharmaceuticals and hormones in the 
environment.  Topics presented in the subsequent chapters include fate studies 
examining sorption, mobility, degradation, and persistence in soil and aquatic 
systems, bioavailability in aqueous systems, ecotoxicological studies, and 
recommendations for risk assessment of veterinary pharmaceuticals. 
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